首页 > 最新文献

Contraception最新文献

英文 中文
Copyright info/Contents 版权信息/内容
IF 2.8 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-11-30 DOI: 10.1016/S0010-7824(24)00476-1
{"title":"Copyright info/Contents","authors":"","doi":"10.1016/S0010-7824(24)00476-1","DOIUrl":"10.1016/S0010-7824(24)00476-1","url":null,"abstract":"","PeriodicalId":10762,"journal":{"name":"Contraception","volume":"141 ","pages":"Article 110762"},"PeriodicalIF":2.8,"publicationDate":"2024-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142757217","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Differential bone calcium retention with the use of oral versus vaginal hormonal contraception: A randomized trial using calcium-41 radiotracer 口服与阴道激素避孕的差异骨钙潴留:一项使用钙-41放射性示踪剂的随机试验。
IF 2.8 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-11-28 DOI: 10.1016/j.contraception.2024.110778
Emily A. Ricker , Mary Jane De Souza , Michael S. Stone , George S. Jackson , George P. McCabe , Linda D. McCabe , Connie M. Weaver

Objectives

This study aimed to assess if hormonal contraception administered orally (combined oral contraceptive pill, COC) or vaginally (contraceptive vaginal ring) differentially affected bone calcium retention in young females.

Study design

Reproductive aged females (18–35 years) not using hormonal contraception were dosed with 50 nCi 41Ca as CaCl2 in 10 mL of sterile saline (0.9%). Following an equilibration phase of ≥100 days and a baseline of two menstrual cycles, participants used COC and the ring for two cycles (49 days) each, in a randomized order, separated and followed by washouts of two menstrual cycles. Twenty-four-hour urine samples were collected monthly during equilibration and every around 10 days during baseline, interventions, and washouts to assess bone calcium retention through accelerator mass spectrometry analysis of the 41Ca:Ca ratio in urine. The effect of each contraception was determined by comparing 41Ca:Ca measured during each contraception intervention to 41Ca:Ca measured during the “control” (baseline and washout) phases using linear models and generalized linear mixed models.

Results

Eight reproductive aged females were studied. Compared with control phases (baseline and washouts), COC resulted in greater bone calcium retention (11.3%, 95% CI: 6.7%, 15.6%). The ring did not alter bone calcium retention (4.2%, 95% CI: −6.6%, 13.9%). COC produced a greater change in calcium retention than the ring (p = 0.03).

Conclusion

Although many factors contribute to bone health, short-term COC improved bone calcium retention, suggesting a potential benefit of COC to bone in females. Conversely, the ring did not alter calcium retention, and may be neither beneficial nor deleterious for bone.

Implications

In this study, the effects of oral (pill) vs. vaginal (ring) hormonal contraception on bone calcium retention were assessed in young females. The pill improved bone calcium retention, suggesting a potential beneficial effect on bone health; the ring did not change bone calcium retention compared with control (no contraception).
目的:本研究旨在评估口服激素避孕(联合口服避孕药,COC)或阴道(避孕阴道环)对年轻女性骨钙潴留的影响是否存在差异。研究设计:未使用激素避孕的育龄女性(18-35岁)在10ml无菌生理盐水(0.9%)中加入50 nCi 41Ca作为CaCl2。在≥100天的平衡期和2个月经周期基线后,参与者按随机顺序使用COC和环各2个周期(49天),分开并随后有2个月经周期的洗脱期。在平衡期间每月收集24小时尿液样本,在基线、干预和冲洗期间每~10天收集一次尿液样本,通过加速质谱分析尿液中41Ca:Ca比值来评估骨钙潴留。通过使用线性模型和广义线性混合模型,将每次避孕干预期间测量的41Ca:Ca与“对照”(基线和洗脱)阶段测量的41Ca:Ca进行比较,确定每种避孕措施的效果。结果:对8名育龄女性进行了研究。与对照期(基线期和冲洗期)相比,COC导致更大的骨钙潴留(11.3%,95% CI: 6.7%, 15.6%)。该环未改变骨钙潴留(4.2%,95% CI: -6.6%, 13.9%)。COC对钙潴留的影响大于环(p=0.03)。结论:尽管许多因素有助于骨骼健康,短期COC可改善骨钙潴留,提示COC对女性骨骼的潜在益处。相反,这个环并没有改变钙潴留,可能对骨骼既没有好处也没有坏处。临床试验注册号:ClinicalTrials.gov ID: NCT02367846注册日期:2015年1月27日。
{"title":"Differential bone calcium retention with the use of oral versus vaginal hormonal contraception: A randomized trial using calcium-41 radiotracer","authors":"Emily A. Ricker ,&nbsp;Mary Jane De Souza ,&nbsp;Michael S. Stone ,&nbsp;George S. Jackson ,&nbsp;George P. McCabe ,&nbsp;Linda D. McCabe ,&nbsp;Connie M. Weaver","doi":"10.1016/j.contraception.2024.110778","DOIUrl":"10.1016/j.contraception.2024.110778","url":null,"abstract":"<div><h3>Objectives</h3><div>This study aimed to assess if hormonal contraception administered orally (combined oral contraceptive pill, COC) or vaginally (contraceptive vaginal ring) differentially affected bone calcium retention in young females.</div></div><div><h3>Study design</h3><div>Reproductive aged females (18–35 years) not using hormonal contraception were dosed with 50 nCi <sup>41</sup>Ca as CaCl<sub>2</sub> in 10 mL of sterile saline (0.9%). Following an equilibration phase of ≥100 days and a baseline of two menstrual cycles, participants used COC and the ring for two cycles (49 days) each, in a randomized order, separated and followed by washouts of two menstrual cycles. Twenty-four-hour urine samples were collected monthly during equilibration and every around 10 days during baseline, interventions, and washouts to assess bone calcium retention through accelerator mass spectrometry analysis of the <sup>41</sup>Ca:Ca ratio in urine. The effect of each contraception was determined by comparing <sup>41</sup>Ca:Ca measured during each contraception intervention to <sup>41</sup>Ca:Ca measured during the “control” (baseline and washout) phases using linear models and generalized linear mixed models.</div></div><div><h3>Results</h3><div>Eight reproductive aged females were studied. Compared with control phases (baseline and washouts), COC resulted in greater bone calcium retention (11.3%, 95% CI: 6.7%, 15.6%). The ring did not alter bone calcium retention (4.2%, 95% CI: −6.6%, 13.9%). COC produced a greater change in calcium retention than the ring (<em>p</em> = 0.03).</div></div><div><h3>Conclusion</h3><div>Although many factors contribute to bone health, short-term COC improved bone calcium retention, suggesting a potential benefit of COC to bone in females. Conversely, the ring did not alter calcium retention, and may be neither beneficial nor deleterious for bone.</div></div><div><h3>Implications</h3><div>In this study, the effects of oral (pill) vs. vaginal (ring) hormonal contraception on bone calcium retention were assessed in young females. The pill improved bone calcium retention, suggesting a potential beneficial effect on bone health; the ring did not change bone calcium retention compared with control (no contraception).</div></div>","PeriodicalId":10762,"journal":{"name":"Contraception","volume":"143 ","pages":"Article 110778"},"PeriodicalIF":2.8,"publicationDate":"2024-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142775612","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Three-year efficacy, safety, and tolerability outcomes from a phase 3 study of a low-dose copper intrauterine device 低剂量铜宫内节育器 3 期研究的三年疗效、安全性和耐受性结果。
IF 2.8 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-11-22 DOI: 10.1016/j.contraception.2024.110771
Mitchell D. Creinin , Lori M. Gawron , Andrea H. Roe , Paul D. Blumenthal , Christy M. Boraas , Melody Y. Hou , Colleen McNicholas , Mary Jo Schreifels , Kevin Peters , Kelly Culwell , David K. Turok , on behalf of the Copper 175mm2 IUD Phase 3 Clinical Investigator Group

Objectives

This study aimed to assess 3-year efficacy, safety, and tolerability of the Cu 175 mm2 intrauterine device (IUD).

Study design

This single-arm trial recruited participants at risk of pregnancy aged 17 to 45 years at 42 U.S. centers to receive a Cu 175 mm2 IUD with a flexible nitinol frame. We assessed efficacy in participants aged ≤35 years at enrollment and assessed all other outcomes in the entire population. We calculated the Pearl Index (pregnancies/100 person-years) through 3 years as the primary efficacy outcome. The secondary outcomes included pregnancy percentages by life-table analysis, placement success, safety (adverse events), and tolerability.

Results

Of 1620 enrollees, 1601 (98.8%) had successful IUD placement, with 1397 aged ≤35 years at enrollment. We observed a 1-year Pearl Index of 0.94 (95% CI 0.43–1.78) and 1-year and cumulative 3-year life-table pregnancy rates of 1.26% (95% CI 0.57%–1.95%) and 2.47% (95% CI 1.34%–3.60%), respectively. The most common adverse events included bleeding and pain. Over 3 years, 15.4% of participants discontinued due to bleeding or pain. Device expulsions occurred in 36 (2.2%) and 63 (3.9%) participants over 1 and 3 years, respectively. Eight related serious adverse events occurred, including five ectopic pregnancies and one each of uterine perforation, anemia, and uterine hemorrhage. One- and three-year continuation rates were 78.9% and 49.6%, respectively.

Conclusions

These data support efficacy, safety, and tolerability of the Cu 175 mm2 IUD during the first 3 years of use.

Implications

In this Phase 3 trial, the investigational Cu 175 mm2 demonstrated efficacy, safety, and tolerability with low rates of expulsion and discontinuation for bleeding and pain-related symptoms. This flexible, nitinol-framed, low-dose copper IUD comes preloaded and would expand contraceptive options beyond the single nonhormonal IUD currently available in the United States.

Clinical Trial

NCT03633799
研究目的评估 Cu 175mm2 铜宫内节育器 (IUD) 的 3 年疗效、安全性和耐受性:这项单臂试验在美国的 42 个中心招募了年龄在 17-45 岁之间的高危妊娠者,让她们接受带有柔性镍钛诺框架的 Cu 175mm2 宫内节育器。我们评估了入组时年龄小于 35 岁的参与者的疗效,并评估了整个人群的所有其他结果。我们计算了 3 年的珍珠指数(怀孕/100 人-年),作为主要疗效结果。次要结果包括通过生命表分析得出的怀孕百分比、置管成功率、安全性(不良事件)和耐受性:在 1620 名注册者中,1601 人(98.8%)成功放置了宫内节育器,其中 1397 人在注册时年龄小于 35 岁。我们观察到 1 年的珍珠指数为 0.94(95%CI 0.43-1.78),1 年和累计 3 年的终身妊娠率分别为 1.26%(95%CI 0.57%-1.95%)和 2.47%(95%CI 1.34%-3.60%)。最常见的不良反应包括出血和疼痛。3 年中,15.4% 的参与者因出血或疼痛而中止治疗。在 1 年和 3 年中,分别有 36 名(2.2%)和 63 名(3.9%)参与者发生了装置脱落。发生了 8 起相关的严重不良事件,其中包括 5 起宫外孕,子宫穿孔、贫血和子宫出血各 1 起。1年和3年的持续率分别为78.9%和49.6%:这些数据支持 Cu 175mm2 宫内节育器在最初 3 年使用期间的有效性、安全性和耐受性:临床试验:NCT03633799。
{"title":"Three-year efficacy, safety, and tolerability outcomes from a phase 3 study of a low-dose copper intrauterine device","authors":"Mitchell D. Creinin ,&nbsp;Lori M. Gawron ,&nbsp;Andrea H. Roe ,&nbsp;Paul D. Blumenthal ,&nbsp;Christy M. Boraas ,&nbsp;Melody Y. Hou ,&nbsp;Colleen McNicholas ,&nbsp;Mary Jo Schreifels ,&nbsp;Kevin Peters ,&nbsp;Kelly Culwell ,&nbsp;David K. Turok ,&nbsp;on behalf of the Copper 175mm2 IUD Phase 3 Clinical Investigator Group","doi":"10.1016/j.contraception.2024.110771","DOIUrl":"10.1016/j.contraception.2024.110771","url":null,"abstract":"<div><h3>Objectives</h3><div>This study aimed to assess 3-year efficacy, safety, and tolerability of the Cu 175 mm<sup>2</sup> intrauterine device (IUD).</div></div><div><h3>Study design</h3><div>This single-arm trial recruited participants at risk of pregnancy aged 17 to 45 years at 42 U.S. centers to receive a Cu 175 mm<sup>2</sup> IUD with a flexible nitinol frame. We assessed efficacy in participants aged ≤35 years at enrollment and assessed all other outcomes in the entire population. We calculated the Pearl Index (pregnancies/100 person-years) through 3 years as the primary efficacy outcome. The secondary outcomes included pregnancy percentages by life-table analysis, placement success, safety (adverse events), and tolerability.</div></div><div><h3>Results</h3><div>Of 1620 enrollees, 1601 (98.8%) had successful IUD placement, with 1397 aged ≤35 years at enrollment. We observed a 1-year Pearl Index of 0.94 (95% CI 0.43–1.78) and 1-year and cumulative 3-year life-table pregnancy rates of 1.26% (95% CI 0.57%–1.95%) and 2.47% (95% CI 1.34%–3.60%), respectively. The most common adverse events included bleeding and pain. Over 3 years, 15.4% of participants discontinued due to bleeding or pain. Device expulsions occurred in 36 (2.2%) and 63 (3.9%) participants over 1 and 3 years, respectively. Eight related serious adverse events occurred, including five ectopic pregnancies and one each of uterine perforation, anemia, and uterine hemorrhage. One- and three-year continuation rates were 78.9% and 49.6%, respectively.</div></div><div><h3>Conclusions</h3><div>These data support efficacy, safety, and tolerability of the Cu 175 mm<sup>2</sup> IUD during the first 3 years of use.</div></div><div><h3>Implications</h3><div>In this Phase 3 trial, the investigational Cu 175 mm<sup>2</sup> demonstrated efficacy, safety, and tolerability with low rates of expulsion and discontinuation for bleeding and pain-related symptoms. This flexible, nitinol-framed, low-dose copper IUD comes preloaded and would expand contraceptive options beyond the single nonhormonal IUD currently available in the United States.</div></div><div><h3>Clinical Trial</h3><div>NCT03633799</div></div>","PeriodicalId":10762,"journal":{"name":"Contraception","volume":"143 ","pages":"Article 110771"},"PeriodicalIF":2.8,"publicationDate":"2024-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142712183","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Copyright info/Contents 版权信息/内容
IF 2.8 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-11-22 DOI: 10.1016/S0010-7824(24)00453-0
{"title":"Copyright info/Contents","authors":"","doi":"10.1016/S0010-7824(24)00453-0","DOIUrl":"10.1016/S0010-7824(24)00453-0","url":null,"abstract":"","PeriodicalId":10762,"journal":{"name":"Contraception","volume":"140 ","pages":"Article 110741"},"PeriodicalIF":2.8,"publicationDate":"2024-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142701578","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Immigration policy climate and contraceptive use among Mexican-origin women in the United States: Support for the “spill-over” hypothesis 移民政策环境与美国墨西哥裔妇女的避孕药具使用情况:支持 "溢出 "假设。
IF 2.8 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-11-22 DOI: 10.1016/j.contraception.2024.110773
Blair G. Darney , Emily R. Boniface , Fernando Riosmena , Evelyn Fuentes-Rivera , Biani Saavedra-Avendaño , Kate Coleman-Minahan

Objectives

This study aimed to examine the association between state-level Immigration Policy Climate (IPC) and the use of most or moderately effective contraceptive methods among US-born White, US-born Mexican-origin, and foreign-born Mexican-origin women.

Study design

We linked nationally representative survey data from three waves of the National Survey of Family Growth (2013–2019) with a novel and dynamic state-level measure of IPC. We compared the use of a most or moderately effective contraceptive method at the time of the survey among the three ethnicity and nativity groups alone and as an interaction with state IPC index score above or below the national mean in the year of the survey. We used multivariable logistic regression to adjust for individual- and state-level characteristics and test for heterogeneity of the effect of IPC.

Results

Weighted study sample included 31,528,602 respondents: 26,029,129 (82.5%; unweighted n = 5441) non-Latina White, 2,958,960 (9.4%; unweighted n = 971) US-born Mexican-origin, and 2,540,513 (8.1%; unweighted n = 719) foreign-born Mexican-origin. After adjusting for confounders, living in a state with a more inclusive immigration policy environment was associated with higher use of moderately or most effective contraception among Mexican-origin respondents, both US- (59.8% vs 52.2% less inclusive) and foreign-born (62.1% vs 55.9% less inclusive), but not US-born White (65.2% vs 67.8% less inclusive) respondents.

Conclusions

Our results support the “spillover” hypothesis; more exclusionary immigration policies were associated with lower utilization of effective contraceptive methods among both US-born Mexican-origin and Mexican immigrant women.

Implications

Mexican-origin women in states with more inclusive immigration policies are more likely to use effective contraception than those in states with exclusionary policies; this suggests that immigration policy climate may “spill over” into US-born Mexican-origin populations.
目的:研究州一级的移民政策环境(IPC)与美国出生的白人、美国出生的墨西哥裔和外国出生的墨西哥裔妇女使用最有效或中等有效避孕方法之间的关系:考察州一级移民政策环境(IPC)与美国出生的白人妇女、美国出生的墨西哥裔妇女和外国出生的墨西哥裔妇女使用最有效或中等有效避孕方法之间的关联:研究设计:我们将全国家庭成长调查(2013-2019 年)三次波次中具有全国代表性的调查数据与一种新颖、动态的州一级 IPC 测量方法联系起来。我们比较了三个种族和原籍群体在调查时单独使用最有效或中等有效避孕方法的情况,以及与调查当年高于或低于全国平均水平的州移民政策环境(IPC)指数得分之间的交互作用。我们使用多变量逻辑回归来调整个人和州一级的特征,并检验 IPC 影响的异质性:加权研究样本包括 31,528,602 名受访者:26,029,129人(82.5%;未加权n=5,441)为非拉丁裔白人,2,958,960人(9.4%;未加权n=971)为墨西哥裔美国人,2,540,513人(8.1%;未加权n=719)为外国出生的墨西哥裔。在对混杂因素进行调整后,居住在移民政策环境更具包容性的州与墨西哥裔受访者中使用中等或最有效避孕药具的比例较高有关,包括美国(59.8% 对 52.2%,包容性较低)和外国出生(62.1% 对 55.9%,包容性较低)受访者,但与美国出生的白人(65.2% 对 67.8%,包容性较低)受访者无关:我们的研究结果支持 "溢出 "假设;在美国出生的墨西哥裔妇女和墨西哥移民妇女中,排斥性较强的移民政策与较少使用有效避孕方法有关:这表明,移民政策环境可能会 "溢出 "到美国出生的墨西哥裔人口中。
{"title":"Immigration policy climate and contraceptive use among Mexican-origin women in the United States: Support for the “spill-over” hypothesis","authors":"Blair G. Darney ,&nbsp;Emily R. Boniface ,&nbsp;Fernando Riosmena ,&nbsp;Evelyn Fuentes-Rivera ,&nbsp;Biani Saavedra-Avendaño ,&nbsp;Kate Coleman-Minahan","doi":"10.1016/j.contraception.2024.110773","DOIUrl":"10.1016/j.contraception.2024.110773","url":null,"abstract":"<div><h3>Objectives</h3><div>This study aimed to examine the association between state-level Immigration Policy Climate (IPC) and the use of most or moderately effective contraceptive methods among US-born White, US-born Mexican-origin, and foreign-born Mexican-origin women.</div></div><div><h3>Study design</h3><div>We linked nationally representative survey data from three waves of the National Survey of Family Growth (2013–2019) with a novel and dynamic state-level measure of IPC. We compared the use of a most or moderately effective contraceptive method at the time of the survey among the three ethnicity and nativity groups alone and as an interaction with state IPC index score above or below the national mean in the year of the survey. We used multivariable logistic regression to adjust for individual- and state-level characteristics and test for heterogeneity of the effect of IPC.</div></div><div><h3>Results</h3><div>Weighted study sample included 31,528,602 respondents: 26,029,129 (82.5%; unweighted <em>n</em> = 5441) non-Latina White, 2,958,960 (9.4%; unweighted <em>n</em> = 971) US-born Mexican-origin, and 2,540,513 (8.1%; unweighted <em>n</em> = 719) foreign-born Mexican-origin. After adjusting for confounders, living in a state with a more inclusive immigration policy environment was associated with higher use of moderately or most effective contraception among Mexican-origin respondents, both US- (59.8% vs 52.2% less inclusive) and foreign-born (62.1% vs 55.9% less inclusive), but not US-born White (65.2% vs 67.8% less inclusive) respondents.</div></div><div><h3>Conclusions</h3><div>Our results support the “spillover” hypothesis; more exclusionary immigration policies were associated with lower utilization of effective contraceptive methods among both US-born Mexican-origin and Mexican immigrant women.</div></div><div><h3>Implications</h3><div>Mexican-origin women in states with more inclusive immigration policies are more likely to use effective contraception than those in states with exclusionary policies; this suggests that immigration policy climate may “spill over” into US-born Mexican-origin populations.</div></div>","PeriodicalId":10762,"journal":{"name":"Contraception","volume":"143 ","pages":"Article 110773"},"PeriodicalIF":2.8,"publicationDate":"2024-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142695372","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association of body mass index on time to fetal expulsion for individuals undergoing medication abortion over 13 weeks gestational duration 妊娠 13 周以上接受药物流产者的体重指数与胎儿排出时间的关系。
IF 2.8 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-11-19 DOI: 10.1016/j.contraception.2024.110752
Megan Fuerst, Kristin C. Prewitt, Bharti Garg, Shaalini Ramanadhan, Leo Han

Objectives

This study aimed to examine the association of body mass index (BMI, kg/m2) with time to fetal expulsion for individuals undergoing medication abortion over 13 weeks.

Study design

This is a retrospective cohort study of singleton pregnancies undergoing medication abortion >13 weeks at a single academic medical center between 2020 and 2024. Our primary outcome was time to fetal expulsion. We categorized BMI into three groups (>25, 25–29.9, and ≥30) and compared median time to fetal expulsion. We used multivariable logistic regression models to assess the association of BMI with time to delivery ≥24hours.

Results

Of the 428 charts reviewed, 382 patients met the inclusion criteria with an average gestational duration of 25.0 weeks. Of these, 162 (42.4%) had a BMI >30 kg/m2; 120 individuals fell into the BMI 25 to 29.9 group (31.4%), and the remaining 100 individuals made up the BMI <25 group (26.2%). The median time to expulsion differed significantly among BMI categories (12 hours for BMI <25 [IQR 8–18], 14 hours for BMI 25–29.9 [IQR 8–22], 20 hours for BMI ≥30 [IQR 12–28], p < 0.001). After adjusting for gestational duration, history of cesarean section, or prior vaginal deliveries, individuals with a BMI ≥30 had 6.62 times the odds (95% CI 3.27–13.44) of having a time to expulsion ≥24 hours compared to BMI <25.

Conclusions

Individuals with a BMI >30 had significantly longer second and third trimester time to fetal expulsion. Induction protocols and counseling may need to be adjusted based on body size.

Implications

Individuals with a BMI >30 undergoing a medication abortion >13 weeks have longer time to fetal expulsion than those with a BMI <25. More research is needed to optimize induction protocols and abortion care for high BMI individuals.
研究目的方法:这是一项回顾性队列研究,研究对象为 2020 年至 2024 年间在一家学术医疗中心接受药物流产超过 13 周的单胎妊娠。我们的主要结果是胎儿排出的时间。我们将 BMI 分成三组(>25、25-29.9 和 ≥30),并比较了胎儿排出的中位时间。我们使用多变量逻辑回归模型评估了 BMI 与分娩时间≥24 小时的关系:在审查的 428 份病历中,382 名患者符合纳入标准,平均妊娠期为 25.0 周。其中,162 人(42.4%)的体重指数大于 30;120 人属于体重指数 25-29.9 组(31.4%),其余 100 人属于体重指数结论组:我们发现体重指数大于 30 的孕妇在第二和第三孕期的胎儿排出时间明显更长。可能需要根据体型调整引产方案和咨询。
{"title":"Association of body mass index on time to fetal expulsion for individuals undergoing medication abortion over 13 weeks gestational duration","authors":"Megan Fuerst,&nbsp;Kristin C. Prewitt,&nbsp;Bharti Garg,&nbsp;Shaalini Ramanadhan,&nbsp;Leo Han","doi":"10.1016/j.contraception.2024.110752","DOIUrl":"10.1016/j.contraception.2024.110752","url":null,"abstract":"<div><h3>Objectives</h3><div>This study aimed to examine the association of body mass index (BMI, kg/m<sup>2</sup>) with time to fetal expulsion for individuals undergoing medication abortion over 13 weeks.</div></div><div><h3>Study design</h3><div>This is a retrospective cohort study of singleton pregnancies undergoing medication abortion &gt;13 weeks at a single academic medical center between 2020 and 2024. Our primary outcome was time to fetal expulsion. We categorized BMI into three groups (&gt;25, 25–29.9, and ≥30) and compared median time to fetal expulsion. We used multivariable logistic regression models to assess the association of BMI with time to delivery ≥24hours.</div></div><div><h3>Results</h3><div>Of the 428 charts reviewed, 382 patients met the inclusion criteria with an average gestational duration of 25.0 weeks. Of these, 162 (42.4%) had a BMI &gt;30 kg/m<sup>2</sup>; 120 individuals fell into the BMI 25 to 29.9 group (31.4%), and the remaining 100 individuals made up the BMI &lt;25 group (26.2%). The median time to expulsion differed significantly among BMI categories (12 hours for BMI &lt;25 [IQR 8–18], 14 hours for BMI 25–29.9 [IQR 8–22], 20 hours for BMI ≥30 [IQR 12–28], <em>p</em> &lt; 0.001). After adjusting for gestational duration, history of cesarean section, or prior vaginal deliveries, individuals with a BMI ≥30 had 6.62 times the odds (95% CI 3.27–13.44) of having a time to expulsion ≥24 hours compared to BMI &lt;25.</div></div><div><h3>Conclusions</h3><div>Individuals with a BMI &gt;30 had significantly longer second and third trimester time to fetal expulsion. Induction protocols and counseling may need to be adjusted based on body size.</div></div><div><h3>Implications</h3><div>Individuals with a BMI &gt;30 undergoing a medication abortion &gt;13 weeks have longer time to fetal expulsion than those with a BMI &lt;25. More research is needed to optimize induction protocols and abortion care for high BMI individuals.</div></div>","PeriodicalId":10762,"journal":{"name":"Contraception","volume":"143 ","pages":"Article 110752"},"PeriodicalIF":2.8,"publicationDate":"2024-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142689384","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Characteristics of patients requesting an abortion beyond 14 weeks of gestation: Retrospective study in Brussels 妊娠 14 周后要求流产的患者特征:布鲁塞尔的回顾性研究。
IF 2.8 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-11-17 DOI: 10.1016/j.contraception.2024.110751
Virginia Morolli , Nassiba Menghoum , Yannick Manigart , Serge Rozenberg

Objectives

The debate over extending the legal time limit for abortion in Belgium has intensified in recent years. Health care providers must refer patients seeking abortion beyond the legal deadline to other countries, such as the Netherlands, where the time limits are more permissive. In light of this situation, we analyzed the demographic and social characteristics of patients requesting abortion after 14 weeks of gestation and compared them with those seeking the procedure within the legal limits.

Study design

This retrospective study examines the sociodemographic characteristics of individuals requesting abortion at City Planning Brussels between January 1, 2022, and March 30, 2023. We employed logistic regression to identify predictive factors for late abortion.

Results

We analyzed 627 abortion requests, with 593 occurring before 14 weeks and 34 after 14 weeks. Patients seeking abortion due to precarity or rape had a higher risk of presenting beyond the legal time limit (odds ratio [OR] 3.64, p = 0.001, and OR 3.96, p = 0.009, respectively). Factors that appeared to reduce this risk included requests for abortion based on personal reasons (lack of desire for a child) and being covered by mutual health insurance (OR 0.22, p < 0.001, and OR 0.25, p = 0.001).

Conclusions

Management of late abortion in Belgium is difficult due to law’s restriction. Our data indicate that the circumstances resulting in late abortion requests are often complex, frequently involving factors such as financial difficulties and precarity. A law modification is necessary to provide uniform and effective care for these patients.

Implications

Since late abortion requests predominantly come from vulnerable patients, revising the law is essential to ensure consistent and equitable care for these individuals. These patients often encounter penalties due to their personal and financial challenges, highlighting the need for a legal framework that better addresses their specific circumstances.
目的:近年来,关于延长比利时堕胎法定期限的争论愈演愈烈。医疗服务提供者必须将超过法定期限要求堕胎的患者转诊到其他国家,如荷兰,因为那里的时间限制更为宽松。鉴于这种情况,我们分析了要求在妊娠 14 周后堕胎的患者的人口和社会特征,并将他们与在法定期限内寻求堕胎手术的患者进行了比较:这项回顾性研究调查了 2022 年 1 月 1 日至 2023 年 3 月 30 日期间在布鲁塞尔市规划局申请堕胎的个人的社会人口学特征。我们采用逻辑回归法来确定晚期人工流产的预测因素:我们分析了 627 例人工流产申请,其中 593 例发生在 14 周之前,34 例发生在 14 周之后。因妊娠不稳定或强奸而寻求人工流产的患者超过法定期限的风险较高(OR 3.64,p = 0.001;OR 3.96,p = 0.009)。降低这一风险的因素包括基于个人原因(不想要孩子)的人工流产请求以及被互助医疗保险覆盖(OR 0.22,p < 0.001;OR 0.25,p 0.001):结论:在比利时,由于法律的限制,晚期人工流产的处理非常困难。我们的数据表明,导致逾期堕胎的情况往往很复杂,经常涉及经济困难和不稳定等因素。有必要修改法律,以便为这些患者提供统一有效的治疗。
{"title":"Characteristics of patients requesting an abortion beyond 14 weeks of gestation: Retrospective study in Brussels","authors":"Virginia Morolli ,&nbsp;Nassiba Menghoum ,&nbsp;Yannick Manigart ,&nbsp;Serge Rozenberg","doi":"10.1016/j.contraception.2024.110751","DOIUrl":"10.1016/j.contraception.2024.110751","url":null,"abstract":"<div><h3>Objectives</h3><div>The debate over extending the legal time limit for abortion in Belgium has intensified in recent years. Health care providers must refer patients seeking abortion beyond the legal deadline to other countries, such as the Netherlands, where the time limits are more permissive. In light of this situation, we analyzed the demographic and social characteristics of patients requesting abortion after 14 weeks of gestation and compared them with those seeking the procedure within the legal limits.</div></div><div><h3>Study design</h3><div>This retrospective study examines the sociodemographic characteristics of individuals requesting abortion at City Planning Brussels between January 1, 2022, and March 30, 2023. We employed logistic regression to identify predictive factors for late abortion.</div></div><div><h3>Results</h3><div>We analyzed 627 abortion requests, with 593 occurring before 14 weeks and 34 after 14 weeks. Patients seeking abortion due to precarity or rape had a higher risk of presenting beyond the legal time limit (odds ratio [OR] 3.64, <em>p</em> = 0.001, and OR 3.96, <em>p</em> = 0.009, respectively). Factors that appeared to reduce this risk included requests for abortion based on personal reasons (lack of desire for a child) and being covered by mutual health insurance (OR 0.22, <em>p</em> &lt; 0.001, and OR 0.25, <em>p</em> = 0.001).</div></div><div><h3>Conclusions</h3><div>Management of late abortion in Belgium is difficult due to law’s restriction. Our data indicate that the circumstances resulting in late abortion requests are often complex, frequently involving factors such as financial difficulties and precarity. A law modification is necessary to provide uniform and effective care for these patients.</div></div><div><h3>Implications</h3><div>Since late abortion requests predominantly come from vulnerable patients, revising the law is essential to ensure consistent and equitable care for these individuals. These patients often encounter penalties due to their personal and financial challenges, highlighting the need for a legal framework that better addresses their specific circumstances.</div></div>","PeriodicalId":10762,"journal":{"name":"Contraception","volume":"143 ","pages":"Article 110751"},"PeriodicalIF":2.8,"publicationDate":"2024-11-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142678002","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Provision of medication and procedural abortion among Massachusetts obstetrician-gynecologists 马萨诸塞州妇产科医生提供药物流产和程序流产的情况。
IF 2.8 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-11-17 DOI: 10.1016/j.contraception.2024.110770
Sara Neill , Avina Joshi , Emily Hoe , Jennifer Fortin , Alisa B. Goldberg , Elizabeth Janiak

Objectives

The aim of the study was to understand the rates of first-trimester medication and procedural abortion provision, sufficiency in abortion training, and factors associated with abortion provision among obstetrician-gynecologists (OB/GYNs) in Massachusetts.

Study design

Electronically fielded surveys of a census of OB/GYNs in Massachusetts in 2021 queried physicians on abortion provision, training, practice type, and demographics. Using weighting to account for nonresponse, we generated estimates of the proportion of OB/GYNS providing abortion and used multivariate regression analysis to explore factors associated with abortion provision including practice type, physician sex, and sufficient abortion training.

Results

A total of 198 OB/GYNs responded to the survey (response rate = 29%). Of 158 OB/GYNs not in training, 55% provide some abortion care. More respondents reported sufficient training for surgical abortion (84%) than for medication abortion (43%). The most cited reasons for not providing abortion care were lack of integration into their clinical practice (29%), institutional opposition (27%), or personal opposition to abortion (23%). In multivariate analysis, female physicians were more likely to provide abortion care (adjusted odds ratio [aOR] 2.72, 95% CI [1.63–4.55], p < 0.01), and those with insufficient training less likely to provide abortion (aOR 0.18, 95% CI [0.10–0.33], p = 0.01). Those in private practice (aOR 0.47, 95% CI [0.28–0.80], p < 0.01) or “other” practice types (aOR 0.16, 95% CI [0.09–0.27], p < 0.01) were less likely to provide abortion compared to physicians in academic practices.

Conclusions

Only half of OB/GYNs in a state supportive of abortion provide abortion. Despite high patient interest in medication abortion, a majority of OB/GYNs report insufficient training in medication abortion.

Implications

This study highlights the need for support from practice, institution, and health system leaders to facilitate the provision of abortion care and the need for increased training among OB/GYNs in medication abortion.
目标:了解马萨诸塞州妇产科医生(OB/GYNs)提供头三个月药物流产和程序流产的比率、流产培训的充分性以及与提供流产服务相关的因素:研究设计:对 2021 年马萨诸塞州的妇产科医生进行电子实地普查,询问医生是否提供人工流产服务、培训、执业类型和人口统计数据。利用加权法考虑非响应因素,我们得出了提供人工流产服务的妇产科医生比例的估计值,并利用多变量回归分析探讨了与提供人工流产服务相关的因素,包括执业类型、医生性别和是否接受过充分的人工流产培训:198名妇产科医生对调查做出了回复(回复率=29%)。在 158 名未接受过培训的妇产科医生中,55% 的医生提供了一些人工流产护理。报告接受过充分手术流产培训的受访者(84%)多于接受过药物流产培训的受访者(43%)。不提供人工流产护理的最主要原因是没有融入临床实践(29%)、机构反对(27%)或个人反对人工流产(23%)。在多变量分析中,女医生更有可能提供人工流产护理(aOR 2.72,95% CI [1.63-4.55],P< 0.01),而那些培训不足的医生更不可能提供人工流产护理(aOR 0.18,95% CI [0.10-0.33],P=0.01)。私人诊所(aOR 0.47,95% CI [0.28-0.80],P< 0.01)或 "其他 "诊所类型(aOR 0.16,95% CI [0.09-0.27],P< 0.01)的医生与学术诊所的医生相比提供人工流产的可能性较低:结论:在支持人工流产的州,只有一半的妇产科医生提供人工流产服务。结论:在支持人工流产的州中,只有一半的妇产科医生提供人工流产服务。尽管患者对药物流产的兴趣很高,但大多数妇产科医生表示药物流产方面的培训不足。
{"title":"Provision of medication and procedural abortion among Massachusetts obstetrician-gynecologists","authors":"Sara Neill ,&nbsp;Avina Joshi ,&nbsp;Emily Hoe ,&nbsp;Jennifer Fortin ,&nbsp;Alisa B. Goldberg ,&nbsp;Elizabeth Janiak","doi":"10.1016/j.contraception.2024.110770","DOIUrl":"10.1016/j.contraception.2024.110770","url":null,"abstract":"<div><h3>Objectives</h3><div>The aim of the study was to understand the rates of first-trimester medication and procedural abortion provision, sufficiency in abortion training, and factors associated with abortion provision among obstetrician-gynecologists (OB/GYNs) in Massachusetts.</div></div><div><h3>Study design</h3><div>Electronically fielded surveys of a census of OB/GYNs in Massachusetts in 2021 queried physicians on abortion provision, training, practice type, and demographics. Using weighting to account for nonresponse, we generated estimates of the proportion of OB/GYNS providing abortion and used multivariate regression analysis to explore factors associated with abortion provision including practice type, physician sex, and sufficient abortion training.</div></div><div><h3>Results</h3><div>A total of 198 OB/GYNs responded to the survey (response rate = 29%). Of 158 OB/GYNs not in training, 55% provide some abortion care. More respondents reported sufficient training for surgical abortion (84%) than for medication abortion (43%). The most cited reasons for not providing abortion care were lack of integration into their clinical practice (29%), institutional opposition (27%), or personal opposition to abortion (23%). In multivariate analysis, female physicians were more likely to provide abortion care (adjusted odds ratio [aOR] 2.72, 95% CI [1.63–4.55], <em>p</em> &lt; 0.01), and those with insufficient training less likely to provide abortion (aOR 0.18, 95% CI [0.10–0.33], <em>p</em> = 0.01). Those in private practice (aOR 0.47, 95% CI [0.28–0.80], <em>p</em> &lt; 0.01) or “other” practice types (aOR 0.16, 95% CI [0.09–0.27], <em>p</em> &lt; 0.01) were less likely to provide abortion compared to physicians in academic practices.</div></div><div><h3>Conclusions</h3><div>Only half of OB/GYNs in a state supportive of abortion provide abortion. Despite high patient interest in medication abortion, a majority of OB/GYNs report insufficient training in medication abortion.</div></div><div><h3>Implications</h3><div>This study highlights the need for support from practice, institution, and health system leaders to facilitate the provision of abortion care and the need for increased training among OB/GYNs in medication abortion.</div></div>","PeriodicalId":10762,"journal":{"name":"Contraception","volume":"143 ","pages":"Article 110770"},"PeriodicalIF":2.8,"publicationDate":"2024-11-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142678021","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Permanent contraception in the childfree population: An exploratory study 无子女人群的永久性避孕:一项探索性研究。
IF 2.8 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-11-08 DOI: 10.1016/j.contraception.2024.110746
Ashley B. Parker , Jessica E. Morse , Amy G. Bryant

Objectives

This study aimed to describe the childfree population seeking permanent contraception, identify barriers to receiving care, and characterize the incidence of regret.

Study design

We conducted a cross-sectional survey of people in the United States, aged 18 years and older, without biological children, and who are seeking or have previously sought a permanent contraception procedure. Participants completed an online REDCap survey distributed over social media platforms, including Reddit, TikTok, and Facebook.

Results

A total of 400 respondents completed the survey, of whom 151 (38%) underwent a permanent contraception procedure, 44 (11%) had found a doctor to perform a procedure but not yet undergone it, 32 (8%) had been unable to find a doctor to do the procedure, 83 (21%) were seeking a doctor, and 90 (22%) had not yet sought a doctor.
Respondents were predominantly White (88%), identified as women (83%), and were diverse in sexual orientation (heterosexual 42%, bisexual 41%). Reasons for seeking permanent contraception included not wanting children (96%), fear of pregnancy/childbirth (70%), the current state of the world (68%), environmental reasons (59%), and medical reasons (32%). Barriers to care included cost of the procedure (30%) and inability to find a doctor who would perform the procedure (42%).
Of the 151 respondents who had undergone a permanent contraception procedure, 70 (46%) asked more than one doctor for the procedure. Of those with permanent contraception, 97% answered “yes” to “Do you think sterilization as a permanent method of birth control was a good choice for you?”

Conclusions

Childfree individuals have a variety of reasons for seeking sterilization and may be at a lower risk of regret than reported in the literature for parous people with permanent contraception.

Implications

Clinicians should be aware of the barriers to permanent contraception for patients who do not desire to have children. Providing patient-centered, individualized care to patients seeking permanent contraception can ensure that patients do not face unnecessary barriers to care and feel heard and empowered to enact their reproductive preferences.
研究目的研究设计:我们对美国 18 岁及以上、无亲生子女、正在寻求或曾经寻求过永久避孕手术的人群进行了横断面调查。参与者完成了通过社交媒体平台(包括 Reddit、TikTok 和 Facebook)发布的在线 REDCap 调查:400名受访者完成了调查,其中151人(38%)接受了永久避孕手术,44人(11%)已找到医生实施手术,但尚未接受手术,32人(8%)无法找到医生实施手术,83人(21%)正在寻找医生,90人(22%)尚未寻找医生。受访者主要为白人(88%),女性(83%),性取向多样(异性恋 42%,双性恋 41%)。寻求永久避孕的原因包括不想要孩子(96%)、害怕怀孕/生孩子(70%)、世界现状(68%)、环境原因(59%)和医疗原因(32%)。接受治疗的障碍包括手术费用(30%)和找不到愿意实施手术的医生(42%)。在 151 名接受过永久性避孕手术的受访者中,有 70 人(46%)找过不止一位医生做手术。在接受过永久性避孕手术的受访者中,97%的人对 "你认为绝育作为一种永久性的节育方法对你来说是一个好的选择吗?"的回答是 "是":无子女者寻求绝育的原因多种多样,其后悔的风险可能低于文献中报道的采取永久性避孕措施的准绝育者:临床医生应了解不想要孩子的患者采取永久性避孕措施的障碍。为寻求永久性避孕的患者提供以患者为中心的个性化护理,可确保患者不会面临不必要的护理障碍,并能感受到自己的生殖偏好得到倾听和授权。
{"title":"Permanent contraception in the childfree population: An exploratory study","authors":"Ashley B. Parker ,&nbsp;Jessica E. Morse ,&nbsp;Amy G. Bryant","doi":"10.1016/j.contraception.2024.110746","DOIUrl":"10.1016/j.contraception.2024.110746","url":null,"abstract":"<div><h3>Objectives</h3><div>This study aimed to describe the childfree population seeking permanent contraception, identify barriers to receiving care, and characterize the incidence of regret.</div></div><div><h3>Study design</h3><div>We conducted a cross-sectional survey of people in the United States, aged 18 years and older, without biological children, and who are seeking or have previously sought a permanent contraception procedure. Participants completed an online REDCap survey distributed over social media platforms, including Reddit, TikTok, and Facebook.</div></div><div><h3>Results</h3><div>A total of 400 respondents completed the survey, of whom 151 (38%) underwent a permanent contraception procedure, 44 (11%) had found a doctor to perform a procedure but not yet undergone it, 32 (8%) had been unable to find a doctor to do the procedure, 83 (21%) were seeking a doctor, and 90 (22%) had not yet sought a doctor.</div><div>Respondents were predominantly White (88%), identified as women (83%), and were diverse in sexual orientation (heterosexual 42%, bisexual 41%). Reasons for seeking permanent contraception included not wanting children (96%), fear of pregnancy/childbirth (70%), the current state of the world (68%), environmental reasons (59%), and medical reasons (32%). Barriers to care included cost of the procedure (30%) and inability to find a doctor who would perform the procedure (42%).</div><div>Of the 151 respondents who had undergone a permanent contraception procedure, 70 (46%) asked more than one doctor for the procedure. Of those with permanent contraception, 97% answered “yes” to “Do you think sterilization as a permanent method of birth control was a good choice for you?”</div></div><div><h3>Conclusions</h3><div>Childfree individuals have a variety of reasons for seeking sterilization and may be at a lower risk of regret than reported in the literature for parous people with permanent contraception.</div></div><div><h3>Implications</h3><div>Clinicians should be aware of the barriers to permanent contraception for patients who do not desire to have children. Providing patient-centered, individualized care to patients seeking permanent contraception can ensure that patients do not face unnecessary barriers to care and feel heard and empowered to enact their reproductive preferences.</div></div>","PeriodicalId":10762,"journal":{"name":"Contraception","volume":"143 ","pages":"Article 110746"},"PeriodicalIF":2.8,"publicationDate":"2024-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142633768","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Conservative political rhetoric and associated enduring threat to constitutional right to abortion—A case study from Brazil 保守派的政治言论和相关的对宪法规定的堕胎权的持久威胁--巴西的案例研究。
IF 2.8 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-11-08 DOI: 10.1016/j.contraception.2024.110737
Roberto Gonzalez Duarte , Israel Júnior Borges Do Nascimento
Abortion is a critical public issue in Brazil where over 800,000 abortions might occur each year, with approximately 250,000 admitted to emergency departments due to complications from unsafe procedures. A new bill seeks to amend the Brazilian Penal Code (Código de Processo Penal), classifying the practice as a felony for patients over 22 gestational weeks, even in cases where the practice is already legally foreseen (e.g., derived from sexual abuse, as an attempt to save pregnant individuals at high risk or due to fetuses’ anencephaly). This bill undermines several Sustainable Development Goals endorsed by the United Nations, particularly those related to health (Goal 3), gender equality (Goal 5), and inequality and poverty reduction (Goal 10). Among the extensive list of potential solutions to the abortion challenge that Brazil currently faces, a feasible and plausible alternative relates to investment in education, in particular sexual education aimed at adolescents.
在巴西,堕胎是一个重要的公共问题,每年可能发生 80 多万例堕胎,约有 25 万人因不安全的堕胎手术引起的并发症而被送进急诊室。一项新法案试图修订《巴西刑法典》(Código de Processo Penal),将妊娠周数超过 22 周的患者的堕胎行为定为重罪,即使是在法律上已经预见到的情况下(例如,源于性虐待、试图挽救高危孕妇或由于胎儿无脑畸形)。该法案破坏了联合国批准的多项可持续发展目标(SDGs),尤其是与健康(目标 3)、性别平等(目标 5)以及不平等和减贫(目标 10)相关的目标。在巴西目前面临的堕胎挑战的众多潜在解决方案中,一个可行且貌似合理的替代方案与教育投资有关,特别是针对青少年的性教育。
{"title":"Conservative political rhetoric and associated enduring threat to constitutional right to abortion—A case study from Brazil","authors":"Roberto Gonzalez Duarte ,&nbsp;Israel Júnior Borges Do Nascimento","doi":"10.1016/j.contraception.2024.110737","DOIUrl":"10.1016/j.contraception.2024.110737","url":null,"abstract":"<div><div>Abortion is a critical public issue in Brazil where over 800,000 abortions might occur each year, with approximately 250,000 admitted to emergency departments due to complications from unsafe procedures. A new bill seeks to amend the Brazilian Penal Code (<em>Código de Processo Penal</em>), classifying the practice as a felony for patients over 22 gestational weeks, even in cases where the practice is already legally foreseen (e.g., derived from sexual abuse, as an attempt to save pregnant individuals at high risk or due to fetuses’ anencephaly). This bill undermines several Sustainable Development Goals endorsed by the United Nations, particularly those related to health (Goal 3), gender equality (Goal 5), and inequality and poverty reduction (Goal 10). Among the extensive list of potential solutions to the abortion challenge that Brazil currently faces, a feasible and plausible alternative relates to investment in education, in particular sexual education aimed at adolescents.</div></div>","PeriodicalId":10762,"journal":{"name":"Contraception","volume":"143 ","pages":"Article 110737"},"PeriodicalIF":2.8,"publicationDate":"2024-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142633528","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Contraception
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1